Gout basics

Bulletin on the Rheumatic Diseases

Volumn 50, Issue 9, 2001, Pages

  Weselman, Kelly O ^a   Agudelo, Carlos A ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0040484969     PISSN: 00075248     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Emmerson BT: The management of gout. New Engl J Med 1996;334(7):445-50.
2. Campion EW, Glynn RJ, DeLabry LO: Asymptomatic hyperuricemia. Amer J Med 1987;82:421-6.
3. Agudelo CA, Wise CM. Crystal deposition disease. In Treatment of the Rheumatic Diseases. 2nd Edition. Weisman M, Weinblatt ME, Louie J Editors. Chapter 35: W.B. Sounders Co. 2001; pp. 447-60.
4. Abubaker MY, Querubin RN. Allopurinol use in the outpatient hospital setting. Arthritis Rheum 1999;42S(9):S173.
5. Baker DG, Schumacher Jr. HR. Acute monoarthritis. New Engl J Med 1993;329(14): 1013-20.
6. Abubaker MY, Querubin RN, Holland W et al. Coexistence of acute gout and septic arthritis. Arthritis Rheum 2000;43(9):S189.
7. Bellamy N, Downie WW, Buckanan WW: Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal anti-inflammatory drugs. Br J Clin Pharmac 1987;24:33-6.
8. Werlen D, Gabay C, Vischer TL: Corticosteroid therapy for the treatment for acute attacks of crystal-induced arthritis: an effective alternative to nonsteroidal anti-inflammatory drugs. Rev Rheum 1996;63(4):248-54.
9. Alloway JA, Moriarty MJ, Hoogland YT et al: Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis. J Rheumatol 1993;20(1):112-3.
10. Groff GD, Franck WA, Raddatz DA: Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Semin Arthritis Rheum 1990;19(6):329-36.
11. Siegel LB, Alloway JA, Nashel DJ: Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment for acute gouty arthritis. J Rheumatol 1994;21:1325-7.
12. Ahern MJ, Reid C, Gordon TP, et al: Does colchicines work? The results of the first controlled study in active gout. Aust NZ Med 1987;17:301-304.
13. Ben-Hetrit E, Levy M: Colchicine: 1998 update. Semin Arthritis Rheum 1998;28(1):48-59.
14. Wallace SL, Singer JZ, Duncan GJ et al: Renal function predicts colchicines toxicity: guidelines for the prophylactic use of colchicine in gout. J Rheumatol 1990;18(2):264-9.
15. Wallace SL, Singer JZ: Review: systemic toxicity associated with the intravenous administration of colchicine - guidelines for use. J Rheumatol 1988;15(3):495-9.
16. Scott JT, Higgens CS: Diuretic induced gout: a multifactorial condition. J Rheum Dis 1992;51:259-61.
17. Wyngaarden JB, Kelley WN. Prognosis in gout. In Gout and Hyperuricemia. Chapter 43: Grime and Stratton 1976; pp. 500-3.